Search CORE

2 research outputs found

Cost-effectiveness of Rosiglitazone Oral Combination for the Treatment of Type 2 Diabetes in Germany

Author: A Bagust
A Bagust
A Bagust
A Liebl
A Liebl
Adrian Bagust
Andreas Liebl
Anita Goertz
Arran T. Shearer
B Kulzer
CJ Currie
Deutsche Diabetes-Gesellschaft
DT Finegood
F Carrl
H Hauner
Hannover Consensus Group
IMS Health Gmbh & Co
International Diabetes Federation
J Raftery
K Hällsten
K Neeser
K Nink
KA Virtanen
KD Palitzsch
LS Phillips
M Nebel
MF Drummond
MR Gold
Oliver Schoeffski
R Klein
R Scheil
RJ Stevens
S Beale
SM Haffner
Statistisches Bundesamt
Statistisches Bundesamt
Statistisches Bundesamt
Statistisches Bundesamt
V Gozzoli
W Rathmann
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain

Author: A Bagust
A Bagust
A Bagust
A Dominguez-Gil
A Goday
A Rodriguez-Carmona
A Shearer
Adrian Bagust
AJ Palmer
Arran T. Shearer
Belén Martínez-Lage Álvarez
CB Rodríguez
CJ Currie
CMBD Insalud
D Kirpichnikov
E Esmatjes
F Carrl
F. Javier Ampudia-Blasco
Farmaindustria
Gonzalo París
Heart Protection Study Collaborative Group
HM Colhoun
IMS
International Diabetes Federation
Isabel Pérez Escolano
IW Campbell
J Cabezas-Cerrato
J Oliva
JA Sacristan
JA Velasco
JA Vázquez
JB Brown
JJ Nolan
JL Clua Espuny
JM Arteagoitia
K Hallsten
K Hällsten
KA Virtanen
KA Virtanen
KM Anderson
M Mata
MF Drummond
MR Gold
R Gisbert
R Klein
RA Fronzo De
RC Eastman
RC Eastman
RJ Stevens
S Beale
Taylor Nelson Sofres Healthcare S.A. (Spain)
Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice
V Kothari
V Ortún
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

core

core